Microbiome FDA Clears First-in-Class Heart Tissue Regeneration Drug for In-Human TrialsBy adminOctober 8, 20250 Credit: Yuichiro Chino/Getty Images In a development that could significantly improve treatment outcomes for patients with heart failure and other…
